1. Home
  2. KYMR vs QBTS Comparison

KYMR vs QBTS Comparison

Compare KYMR & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$90.68

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$19.65

Market Cap

7.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
QBTS
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
7.8B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
KYMR
QBTS
Price
$90.68
$19.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
24
15
Target Price
$105.96
$32.80
AVG Volume (30 Days)
713.8K
23.0M
Earning Date
04-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,072,000.00
N/A
Revenue This Year
$19.43
$196.47
Revenue Next Year
N/A
$60.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.45
$4.45
52 Week High
$103.00
$46.75

Technical Indicators

Market Signals
Indicator
KYMR
QBTS
Relative Strength Index (RSI) 70.21 43.42
Support Level $66.33 $18.55
Resistance Level $103.00 $19.51
Average True Range (ATR) 4.13 1.56
MACD 1.03 0.15
Stochastic Oscillator 81.31 55.62

Price Performance

Historical Comparison
KYMR
QBTS

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: